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Insights into Distinct Modulation of 7 and 72 Nicotinic
Acetylcholine Receptors by the Volatile Anesthetic
Isoflurane*□S
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Background: What determines hypersensitivity or insensitivity of 2-containing or 7 nAChRs to volatile anesthetics
remains unclear.
Results: Isoflurane binds to the EC end of the TM domain, modulates channel dynamics, and inhibits channel current in 2 not 7.
Conclusion: The dynamic and structural differences between 2 and 7 affect isoflurane binding and inhibition.
Significance: Both structure and dynamics are critical for drug action.
Nicotinic acetylcholine receptors (nAChRs) are targets of
general anesthetics, but functional sensitivity to anesthetic inhi-
bition varies dramatically among different subtypes of nAChRs.
Potential causes underlying different functional responses to
anesthetics remain elusive. Here we show that in contrast to the
7 nAChR, the 72 nAChR is highly susceptible to inhibition
by the volatile anesthetic isoflurane in electrophysiology mea-
surements. Isoflurane-binding sites in 2 and 7 were found at
the extracellular and intracellular end of their respective trans-
membrane domains using NMR. Functional relevance of the
identified 2 site was validated via point mutations and subse-
quent functional measurements. Consistent with their func-
tional responses to isoflurane, 2 but not 7 showed pro-
nounced dynamics changes, particularly for the channel gate
residue Leu-249(9). These results suggest that anesthetic bind-
ing alone is not sufficient to generate functional impact; only
those sites that canmodulate channel dynamics upon anesthetic
binding will produce functional effects.
Neuronal nicotinic acetylcholine receptors (nAChRs)2 are
pentameric ligand-gated ion channels (pLGICs) that mediate
the fast synaptic response in the central and peripheral nervous
systems. They are composed of (2–10) and (2–4) sub-
units and assemble to form either homo- or hetero-pLGICs.
The 7 subunit mainly forms homo-pLGICs, but it can also
assemble with 2 or 3 subunits to form hetero-pLGICs (1–3).
nAChRs have been implicated in general anesthesia and play
roles in memory (4), nociception (5), and the autonomic
response (6). Different subtypes of nAChRs show distinct sen-
sitivities to general anesthetics (7–9), even though they share
high sequence homology. For instance, the 7 nAChR is insen-
sitive to volatile anesthetics at clinically relevant concentra-
tions, whereas the 42 nAChR is hypersensitive (8, 9). The
underlying cause, however, remains elusive.
High resolution structures of the full-length neuronal
nAChRs, including 42 and 7, have not been solved. How-
ever, NMR structures for the TM domains of 4, 2, and 7
subunits have been recently determined (Protein Data Bank
codes 2LLY, 2LM2, and 2MAW) (10). The 4 Å resolution cryo-
electron microscopy structure of the Torpedo marmorata
nAChR (11) reveals overall structural features of nAChRs.
Each subunit has an extracellular (EC) domain containing
the orthosteric ligand binding site, a transmembrane (TM)
domain composed of four TM helices, of which TM2 lines
the pore and contains the channel gate, and an intracellular
(IC) domain. High resolution x-ray structures of bacterial
homologues fromGloebacter violaceous (GLIC) and Erwinia
chrysanthemi (ELIC) demonstrate the same structural scaf-
fold (12–18).
Previously, we investigated potential causes for different
sensitivities of the 42 and 7 nAChRs to volatile general
anesthetics using molecular dynamics simulations (19–21).
Although multiple anesthetic binding sites were observed in
7,4, and2 subunits, anesthetic binding to a site at the inter-
face between EC and TM domains of 2 produced a profound
change in protein dynamics that was likely to affect channel
function. On the basis of the simulation results, we proposed
that the susceptibility to anesthetic perturbation in 2, but not
in 7, underlies the functional sensitivity of 42 and insensi-
tivity of 7 to volatile anesthetics (19). We also predicted that
* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealth
Grants R01GM56257 and R01GM66358 (to P. T.) and R37GM049202 (to
Y. X.).
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unlike 7, 72 would be sensitive to volatile anesthetics
because of the involvement of 2 (19).
In the present study, we revealed different functional
responses of the 72 and 7 nAChRs, expressed in neurons
and Xenopus laevis oocytes, to the anesthetic isoflurane. We
also determined the binding sites and dynamic effects of isoflu-
rane on both the 7 and 2 nAChR TM domains using NMR,
validated the functional relevance of the identified isoflurane
site via point mutations and subsequent functional measure-
ments, and rationalized potential causes underlying the insen-
sitivity of the 7 channel and the hypersensitivity of the 72
channel to isoflurane. The study provides compelling evidence
that isoflurane binds to both 7 and 2, but at different loca-
tions. More importantly, isoflurane binding induced pro-
nounced dynamics changes in 2, particularly for the channel
gate residue Leu-249(9). In contrast, isoflurane binding to 7
did not generate the same dynamics changes. The study con-
veys a message that only those sites able to modulate protein
dynamics upon anesthetic binding will produce functional
effects.
EXPERIMENTAL PROCEDURES
Electrophysiology Measurements—Neuron dissociation and
patch clamp whole cell current recordings were performed as
reported previously (3). Briefly, several 400-m coronal slices
from postnatalWistar rats (2–3 weeks old) containing the ven-
tral diagonal band (VDB) or the ventral tegmental area (VTA)
were cut in cold (2–4 °C) artificial cerebrospinal fluid. The
slices were incubated for at least 1 h in oxygenated artificial
cerebrospinal fluid at room temperature (22  1 °C). Thereaf-
ter, the slices were treatedwith Pronase (1mg/6ml) at 31 °C for
30 min. The medial septum/diagonal band or VTA region was
micropunched out from the slices using a well polished needle.
Each punched piece was then dissociated mechanically using
several fire-polishedmicro-Pasteur pipettes in a 35-mmculture
dish filledwithwell oxygenated, standard external solution (150
mMNaCl, 5 mMKCl, 1 mMMgCl2, 2 mMCaCl2, 10 mM glucose,
and 10 mM HEPES, pH 7.4, with Tris-base). The separated sin-
gle cells usually adhered to the bottom of the dish within 30
min.Human7-nAChRwas expressed heterologously in trans-
fected SH-EP1 human epithelial cells as described in detail pre-
viously (22).
Functional measurements were performed using perforated
patch whole cell recordings coupled with a two-barrel drug
application system (3). After the formation of whole cell con-
figuration, an access resistance less than 30 M was acceptable
for voltage-clamp recordings. The series resistance was not
compensated in the experiments using dissociated neurons.
The data were filtered at 2 kHz, acquired at 11 kHz, and digi-
tized on-line (Digidata 1322 series A/D board; Axon Instru-
ments, Foster City, CA). All experiments were done at room
temperature (22 1 °C). Clampex 9.2 (Axon Instruments) was
used for data acquisition, and Prism 3.0 (Prismsoft Inc.) was
used for graphics and statistical calculation. For statistical anal-
ysis ofmultiple groups of data, one-way ormultivariate analysis
of variance followed by appropriate test was applied. p  0.05
was considered significant, and the data are represented as
mean S.E.
To ascertain the different sensitivity of 72 and 7 to iso-
flurane observed in neurons, we also used Xenopus laevis
oocytes for channel expression and functional measurements.
The plasmids encoding human 7 and 2 nAChRs for oocyte
expression were gifts from Prof. Lindstrom’s lab at the Univer-
sity of Pennsylvania and Prof. Henry Lester’s lab at the Califor-
nia Institute of Technology, respectively. To reconcile the
structural and functional data, we constructed two mutants
(7-M22V and 72-V22M) for functional measurements in
oocytes. The mutations were introduced by QuikChange light-
ning site-directed mutagenesis kit (Agilent) and confirmed
by DNA sequencing. cRNAs were synthesized for 7 and
7-M261V(M22V) with the mMessage mMachine SP6 kit
(Ambion) and for 2 and 2-V22M with the mMessage
mMachine T7 kit (Ambion). The cRNAswere purified with the
RNeasy kit (Qiagen).
Channel functions of Xenopus laevis oocytes (stages 5–6)
expressing native and mutant nAChRs were measured by two-
electrode voltage clamp experiments. For making 72, the
RNAs of 7 and 2 were injected to each oocyte in a 1:1 ratio
with a total of 25 ng. The injected oocytes were maintained at
18 °C in a modified Barth’s solution (17). After being expressed
for 24–36 h, the oocyte in a 20-l recording chamber (Auto-
mate Scientific) and the ND96 buffer (23) was clamped with an
OC-725C Amplifier (Warner Instruments) to a holding poten-
tial of 60 mV, and currents elicited by acetylcholine and
modulated by 50-M isoflurane were recorded. The collected
data were processed using Clampex 10 software (Molecular
Devices).
NMRExperiments—NMR samples of the TMdomains of the
7 and 2 human nAChRs were prepared using the protocols
as reported in detail previously (10). Each NMR sample at pH
4.7 contained 0.25–0.3 mM protein, 40–60 mM lauryldimeth-
ylamine-oxide (LDAO) detergent, 5 mM sodium acetate, 10 mM
NaCl, 20mM2-mercaptoethanol to prevent disulfide bond forma-
tion, and 5%D2O for deuterium lock inNMRmeasurements. The
anesthetic isofluranewas titrated into the samples using a gas tight
microsyringe. The isoflurane concentration was quantified based
on 19F NMR using themethod reported previously (24).
All NMR spectra were acquired on a Bruker Avance 600
MHz spectrometer, which was equipped with a triple-reso-
nance inverse detection TCI cryoprobe (Bruker Instruments,
Billerica, MA). 1H-15N TROSY-HSQC spectra were acquired
with 1-s relaxation delay for each sample before and after add-
ing isoflurane. Spectral windows were typically 13 ppm (1,024
data points) in the 1H dimension and 22 ppm (128 data points)
in the 15N dimension. The 1H chemical shifts were referenced
to the DSS resonance at 0 ppm, and the 15N chemical shifts
were indirectly referenced (25).
The collected NMR data were processed using NMRPipe 4.1
and NMRDraw 1.8 (26) and analyzed using Sparky 3.10 (27).
Each processed spectrum had 4,096 512 data points. 1H and
15N chemical shift assignments for the 7 and 2 TM domains
in the presence of isoflurane were referenced to the previous
assignments for the same proteins without drugs (10). Chemi-
cal shifts and peak intensities in the NMR spectra were mea-
sured using Sparky 3.10 (27).
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Visualization of Isoflurane Binding andCalculation of Cavity
Volumes and Angles between TM2 and TM4—To assist visual-
izing isoflurane-binding sites identified by NMR experiments,
we performed docking of isoflurane to NMR structures of the
7 and 2 TM domains. The targeted docking kept only those
sites consistent with the NMR results. Docking was performed
with Autodock4 (28) using a Lamarckian genetic algorithm
with a grid spacing of 0.375 Å. For each intrasubunit binding
site suggested by the NMR data, 250 independent anesthetic
dockings were performed within a cube covering 6,600 Å3
using an initial population size of 500.
The sizes of intersubunit cavities for isoflurane binding were
calculated using the POVME algorithm (29). A grid encom-
passing the cavity in each of the 20 NMR structures of 7 or 2
was generated with 0.5 Å grid spacing. The algorithm provided
the grid points defining the cavity, which represent a subset of
the total cavity points. Using MATLAB, we determined the
frequency that each point was observed in the bundle of 20
NMR structures for 7 or 2. Points shown from at least five
structures were used for highlighting the cavity in Fig. 3.
Reported cavity volumes are the means  S.E. of the volumes
calculated for the 20 NMR structures. The VMD program (30)
was used for visualizing molecular structures and generating
figures.
The angles between TM2 and TM4 helices near the EC end
of the TM domain were calculated for each of 20 structures for
2 or 7. Vectors were fit to backbone atoms of TM2 (residues
from Lys-260 to Leu-249 in 2 and fromGlu-259 to Leu-248 in
7) and TM4 (residues from Leu-454 to Phe-443 in 2 and
from Met-466 to Val-455 in 7). Angles were calculated using
the cross product of the two vectors. The values reported are
the mean differences between the 2 and 7 angles  the
pooled standard error, SEP,
SEp Sp 1n1 1n2 (Eq. 1)
where
Sp n1 1	s12 n2 1	s22n1 n2 2 (Eq. 2)
and where n1 and n2 represent the two sample sizes, and s1 and
s2 represent the two standard deviations.
RESULTS
The 72 nAChR Is Much More Sensitive to Isoflurane Inhi-
bition Than the 7 nAChR—Our previous pharmacological,
cell biological, and single-cell RT-PCR studies confirmed the
expression, localization, and assembly of72 nAChRs in VDB
neurons (3). Here, we used the same dissociated VDB neurons
to test functional responses of 72 nAChRs to the volatile
anesthetic isoflurane. As shown in Fig. 1, the inward currents
were generated by application of 10 mM choline, an agonist for
7-containing nAChRs, in acutely dissociated neurons from
mouse VDB at a holding potential of 60 mV. The peak cur-
rents were significantly reduced by 10M isoflurane after 2min
of isoflurane preincubation. Isoflurane preincubation reduced
the maximal choline-induced activation by 37 8%. The EC50
and Hill coefficient had no significant changes (p
 0.58) in the
absence (3.8  0.3 mM; 1.35  0.32) and presence (4.1  0.5
mM; 1.23 0.18) of 10M isoflurane, suggesting that isoflurane
inhibition occurs in a noncompetitive manner (Fig. 1a). Isoflu-
rane inhibition of72-nAChR-mediatedwhole cell current in
acutely dissociated neurons from mouse VDB was concentra-
tion-dependentwith an IC50 of 11.7 1.6M (Fig. 1b), less than
0.1 minimum alveolar concentration in human (31, 32). We
FIGURE1. Isoflurane inhibited functionof the72butnot7nAChRs.a,
the 72 nAChRs expressed in VDB neurons were noncompetitively inhib-
ited by 2 min of preincubation with 10 M isoflurane (Iso). EC50 of choline
(Cho) and Hill coefficients show no significant differences in the absence and
presence of isoflurane. b, isoflurane inhibited 72 with an IC50 of 11.7 1.6
M. Fractional currents were obtained from the mean peak currents elicited
by 10 mM choline (EC70). The error bars are standard errors (n
 6). c, repre-
sentativewhole cell current traces for72 expressed in VDBneurons, native
7 in VTAneurons, andheterologously human7nAChRs in the SH-EP1 cells.
The vertical and horizontal scales represent 50 pA and 250ms, respectively. d,
normalized mean ( S.E.) peak current responses of 72 and 7 expressed
in various cells to the prolonged choline stimulation in the presence of 10M
isoflurane (n
 6). Isoflurane inhibited choline-induced currents in 72, but
not in7. e–h, representative current traces for72 (e),7 (f), the7-M22V
mutant (g), and the 72-V22M mutant (h) expressed in Xenopus oocytes.
The currents were elicited by acetylcholine at the EC20, modulated by isoflu-
rane (50 M), and recorded by two-electrode voltage clamp at60 mV. The
vertical and horizontal scales represent 25 nA and 1 min, respectively.
Determinants of Functional Sensitivity to Anesthetics
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measured isoflurane inhibition by using a repeated application
protocol, in which choline was applied at 2-min intervals in the
continuous presence of 10 M isoflurane. Isoflurane progres-
sively inhibited 72 currents. Reversibility of isoflurane inhi-
bition was demonstrated by the current recovery after 4 min of
isoflurane washout. In contrast to 72, the homomeric 7
expressed either in neurons dissociated fromVTA (33) or in the
SH-EP1 cells (22) are not sensitive to 10 M isoflurane (Fig. 1, c
and d). This is consistent with an IC50 of 600 M (2 mini-
mum alveolar concentration) for the human 7 nAChR
reported previously (34). Different sensitivities to isoflurane
inhibition were also observed in the recombinant 72 and 7
nAChRs expressed in Xenopus laevis oocytes. Representative
current traces obtained from oocytes (Fig. 1, e and f) echo the
message conveyed by the results from the dissociated neurons
(Fig. 1, a–d). In addition, we found that a swap of residue 22
between 7 and 2 had a dramatic impact on isoflurane inhi-
bition (Fig. 1, g and h). Although 7 is insensitive to isoflurane
inhibition, themutant7-M261(22)V showed 39 7% (n
 6)
isoflurane inhibition, similar to that (46 3%, n
 4) observed
on 72. Conversely, the mutant 72-V262(22)M, similar to
7, showed a lower sensitivity to isoflurane inhibition (12 2%,
n
 4). Altogether, these data suggest an indispensible role for
2 and the importance of its residue Val-262(22) in isoflurane
inhibition.
2 and 7 Have Different Isoflurane-binding Sites in Their
TM Domains—We investigated the binding sites of isoflurane
in the TMdomains of 2 and 7 nAChRs using high resolution
NMR. As shown in the 1H-15NTROSY-HSQC spectra (Fig. 2, a
and b), the presence of 1.3 or 1.6 mM isoflurane perturbed a
number of residues in 2 or 7 nAChRs, respectively. The res-
idues with either more than 40% intensity change or a com-
bined chemical shift change (35) greater than 15 ppb (2) and
10 ppb (7) were mapped onto NMR structures of the 2 or 7
TM domains (Fig. 2, c and d). Intrasubunit pockets for isoflu-
rane binding were found in the NMR structures of 2 and 7,
but at different sites: the one in 7 is close to the intracellular
end of the TMdomain, and the one in 2 is at the EC end of the
FIGURE 2. Isofluranebinding to the TMdomains of2 and7. a and b, 1H-15N TROSY-HSQC spectra of2 (a) and7 (b) in the presence (green) and absence
(black) of 1.3 or 1.6 mM isoflurane, respectively. Residues showing significant changes in chemical shift or peak intensity are labeled and highlighted with red.
Residues labeled in blue are pore-lining residues. Full chemical shift assignments for 2 and 7 TM domains are provided in supplemental Figs. S1 and S2,
respectively. c, thebundleof 20NMRstructures of the2TMdomain (ProteinDataBank code2LM2)mappedwith residueshighlighted in red ina.d, thebundle
of 20NMRstructures of the7TMdomain (ProteinData Bank code2MAW)mappedwith residueshighlighted in red inb. Residues are coloredbasedon residue
type: green, polar;white, nonpolar; and blue, basic. Docked isoflurane is shown inmagenta.
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TM domain, which is also the site for halothane and ketamine
binding (36).Moreover, this anesthetic site in2 is homologous
to the previously identified anesthetic site in GLIC (37), ELIC
(18), and the Torpedo nAChR (38). The isoflurane site in 7 is
homologous to a halothane binding site at the IC end of the 2
TM domain identified by NMR and coincides with one of the
halothane sites in 7 predicted by our previous molecular
dynamics simulations (19).
Some residues, including the channel gate residue Leu-
249(9) in 2, showed significant changes upon the addition of
isoflurane but are structurally remote from the cluster of resi-
dues defining the binding pocket. Their changes likely result
from allosteric effects rather than direct contact with isoflu-
rane. It is also worth noting that several pore-lining residues in
2, but not7, showed greatly reduced intensity upon the addi-
tion of isoflurane, indicative of motional changes for these
residues.
A Smaller Intrasubunit Pocket Excludes Isoflurane Binding to
the EC end of the 7 TM Domain—To determine why isoflu-
rane binds to the EC end of the TMdomain in 2 but not in 7,
we examined the pocket in this region based on NMR struc-
tures of the 2 and 7 TM domains. Mostly hydrophobic resi-
dues and a few hydrophilic residues from four TM helices line
the intrasubunit pocket near the EC end of the TM helices in
both 2 and 7. The average cavity volumes are 179  12 and
122 10Å3 for2 and7, respectively (Fig. 3). The differences
in cavity volume primarily result from tighter packing of four
helices in the region of 7 and greater side chain volume of
several cavity-lining residues in 7, such as 7-M261(22) ver-
sus 2-V262(22), 7-I271 versus 2-V272, and 7-F275 versus
2-L276. The differences in isoflurane inhibitionmade by these
residues were evident in functional measurements of the
mutants 7-M261(22)V and 72-V262(22)M (Fig. 1, g and
h). Helical tilting differences (6.7  1.3°), measured by angles
between TM2 and TM4 (Fig. 3d), also contribute to different
cavity volumes at the EC end of theTMdomain between2 and
7. Both the inward helical tilting of 7 and the more bulky
M22 side chain in 7 contribute to a smaller cavity. Further-
more, orientations of side chains also affect the cavity volumes.
For the residues in TM3, both side chains of 2-V272 and
2-L276 are oriented away from the cavity, whereas the equiv-
alent residues 7-I271 and 7-F275 are oriented toward the
cavity. A smaller cavity in the EC end of the TM domain in 7
has reduced the probability of isoflurane binding to the region,
considering that isoflurane has a volume of 144 Å3 (39).
Isoflurane Modulates the Dynamics of 7 and 2 Differently—
One of the most striking differences between 7 and 2 is that
upon isoflurane binding, 7 retained a single signal for each
residue in the NMR spectra, but 2 showed classic examples of
two-site chemical exchange (40, 41) for several residues, includ-
ing the channel gate residue Leu-249(9) and Val-262(22) lin-
ing the isoflurane-binding pocket in 2. As shown in Fig. 4, in
the absence of isoflurane (black), each of these 2 residues
showed a single peak in the NMR spectrum. After adding 1.3
mM isoflurane (red), an additional peak became observable for
Leu-248 and Thr-265 (denoted as Leu-248 and Thr-265,
respectively).When the isoflurane concentrationwas increased
to 3 mM (cyan), Leu-249 and Val-262 also showed additional
peaks. The combined chemical shift change between each pair
of peaks (A-B or A-B), HN
 [(H2 N2)]1⁄2 is 32, 27,
37, 32 Hz for Leu-248, Leu-249, Val-262, and Thr-265 of 2,
respectively. Based on the consensus frommany previous stud-
ies (40–42), the occurrence of two distinct peaks for a residue
indicates a slow exchange with kex 2HN 200 s1.
Conformational exchange among 2 residues also shows
some differences. For residues Leu-248 and Thr-265, peak A
remained at 20-Hz line width and the same resonance fre-
quency in the absence and presence of isoflurane, indicating a
possibility that slow conformational exchange with an
extremely lowpopulation for the second conformation (peak B)
already existed in the absence of isoflurane. Isoflurane shifted
the equilibria between the two conformations. Indeed, the pop-
ulation of conformation B, pB 
 1  pA, increased from 0 to
0.3 andmore than0.5when isofluranewas increased from0
to 1.3 and 3 mM. Overall, Leu-248 and Thr-265 fit well to the
scheme of slow exchange between two conformations (40–42).
In the case of Leu-249 and Val-262, however, a single peak with
a broader line width in the 1H dimension was observed in the
presence of 0 mM (Leu-249, 21 Hz; Val-262, 17 Hz) and 1.3 mM
isoflurane (Leu-249, 19 Hz; Val-262, 16 Hz), but two narrower
peaks (Leu-249, 16 and 12 Hz; Val-262, 14 and 12 Hz) were
observed in the presence of 3mM isoflurane. The results suggest
that Leu-249 and Val-262 were likely in an intermediate
exchange regime (40, 41) before being exposed to 3 mM isoflu-
rane. In addition to slower exchange between A and B confor-
mations, the increased isoflurane concentration also shifted
peak A from peak A by 14 and 11 Hz for Leu-249 and Val-262,
respectively (Fig. 4). This is not unexpected, considering that
multiple conformers with subtle differences can coexist in a
functional state (43, 44). The sensitivity of 2 and insensitivity
of 7 to the dynamics modulation by isoflurane are in good
agreement with their distinctly different functional responses
to isoflurane inhibition.
FIGURE 3. The intrasubunit cavity at the EC end of the TM domain in 2, but not in 7, can accommodate isoflurane binding. a, alignment of 20 NMR
structures with the lowest target function for 2 (blue) and 7 (yellow), and the cavities of 2 (blue) and 7 (red), outlined by grid points present in at least five
of the 20 structures. b and c, residues highlighted with the side chain bundles (shown in stick representation) in 2 (b) and 7 (c) have primary responsibility
for the different cavity volumes. Note that in 2, the cavity can accommodate isoflurane (purple surface), but the cavity in 7 (dotted outline) cannot do the
same. d, the top view of the lowest target function structures of 2 (blue) and 7 (yellow) shows different orientations of TM helices.
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DISCUSSION
Our functional data substantiate the previous prediction (19)
that, unlike the 7 nAChR, the 72 nAChR is sensitive to
anesthetic inhibition. The result highlights the role of 2 in
functional modulation by volatile anesthetics and supports our
hypothesis that 2 is primarily responsible for the difference of
anesthetic susceptibility between 42 and 7 (19). More
importantly, the result conveys the message that two or three
subunits susceptible to anesthetics, such as 2 in 72, are
sufficient to produce functional effects. The message is consis-
tent with the notion obtained from molecular dynamics simu-
lations of anesthetic propofol action in GLIC (45).
Why is 2 more susceptible to volatile anesthetics than 7?
This key question has been addressed by ourNMRexperiments
from three aspects. First, 2 and 7 show some structural dif-
ferences in their TM domains, even though they share a com-
mon scaffold. The most notable difference lies in the size of an
intrasubunit cavity near the EC end of the TM domain that is
large enough in 2, but not in 7, to accommodate isoflurane
binding. Second, the structural difference leads to different
binding locations for isoflurane, which binds to the cavity at the
EC end of theTMdomain in2 but to a pocket located at the IC
end of the TM domain in 7. Finally, differences in their struc-
tures and isoflurane-binding sites may have contributed to dif-
ferent dynamics responses of 2 and 7 to isoflurane binding.
Only in 2 were isoflurane-induced changes in conformational
populations andmotion on thes-ms time scale observed. The
combined effects from structures, anesthetic binding sites, and
dynamics modulations may have contributed to the functional
differences between 2 and 7.
The sequence identity between 2 and 7 is high,50% for
the TMdomain and close to 65% for the pore-lining TM2 helix.
Their sequence homology is even higher (Fig. 5). Our results
demonstrate that variation in a small number of residues is
sufficient to make differences in protein structures, drug-bind-
ing sites, and functional responses to drug binding. The func-
tional significance of such small changes in structure highlights
the necessity of solving individual protein structures, even for
highly homologous proteins. In the case of 2 and 7, the
homologous cavity-lining residues2-V22 and7-M22make
a notable difference for their respective cavities, isoflurane
binding, and isoflurane inhibition. Indeed, a single 7-M22V
mutation markedly increased the channel sensitivity to isoflu-
rane, and the 72-V22Mmutation had a reverse effect. This
result is consistent with the diminished sensitivity to volatile
anesthetics observed previously for the I22M mutation in the
3 containing nAChR (46). A larger volume and extended side
FIGURE 4.Different dynamics responses of2 and7 to isofluranemodulation.Overlay of NMR spectra for individual residues in2 (a–d) and7 (e–h) in
thepresenceof isoflurane: 0mM (black), 1.3mM for2and1.6mM for7 (red), and3.0mM for2and3.3mM for7 (cyan). Note thatnoneof the7 residues show
an additional conformation over the isoflurane concentration range used in the experiments. The peaks representing the different conformations for 2 are
labeled A, A, and B.
FIGURE 5. Sequence alignments for TM domains of human 7 and 2
nAChRs. Sequences of the constructs used for NMR samples,7 and2, are
alignedwith their respective native sequences. Note that only a few terminal
and loop residueswere changed to increase the stability ofNMR samples. The
labeled sequence numbers are for the7 nAChR. The pore lining residues are
labeled using the conventional prime numbering. Residues in the box were
mutated in the study.
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chain conformation ofMet-22 can effectively reduce the cavity
volume and obstruct drug binding. Moreover, methionine may
also stabilize the TM2 helix andmake it more resilient to struc-
tural and dynamic perturbation introduced by anesthetic bind-
ing. Previous studies using unnatural amino acid substitutions
have shown that residues with unbranched side chains, such as
methionine and alanine, have a more stabilizing effect on 
helices than branched amino acids, such as valine and isoleu-
cine (47). Similarly, 2-S19 and 7-A19 could also make
dynamics differences to the TM2 helix. Alanine is a natural
helix promoter (48), whereas serine and threonine often disrupt
-helices because of backbone to side chain hydrogen bonds
(49, 50). Our previousNMR study noted heightened conforma-
tional dynamics at the EC end of TM2 for the glycine receptor,
which is uniquely richwith serines in this region comparedwith
other pLGICs (51). Contributions to the anesthetic binding site
from two pairs of residues in TM3, 2-L276/7-F275 and
2-V272/7-I271, should also not be underestimated. Muta-
tion on the homologous residue in GLIC was found to signifi-
cantly affect the susceptibility of the channel to the anesthetics
desflurane and propofol (37).
The anesthetic binding site at the EC end of the TM domain,
as revealed for isoflurane in 2, is probably a common site in
pLGICs for anesthetics. Using NMR, we found that the anes-
thetics halothane and ketamine bound to the same site in 2
(36). The site is also consistent with one of the halothane sites
identified by photo affinity labeling in the Torpedo nAChR (38)
and by fluorescence quenching in GLIC (52). The anesthetics
desflurane and propofol were found in the homologous site in
the crystal structures of GLIC bound with these anestethics
(37). Functional and mutation studies on the 7/3 nAChR
chimeras also underscored the importance of the cavity to inhi-
bition by the volatile anesthetic halothane (46). In contrast,
anesthetic binding to the IC end of the TMdomain, as observed
for isoflurane in 7 in this study, is less effective to perturb
channel function. Isoflurane inhibits 7 only at concentrations
higher than those used clinically (34).
Our results provide evidence that functional insensitivity of
7 to volatile anesthetics is not due to a lack of anesthetic bind-
ing, at least in the case of isoflurane. The hypersensitivity of
72 and the insensitivity of 7 suggest that the EC end of the
TM domain plays a critical role for channel gating in pLGICs.
Increasing the rigidity of residues at the EC end of the TM
domain can make the channel less responsive to activation sig-
nals. Many previous studies support this notion. Increasing he-
lical flexibility at the EC end of TM2 of the nAChRwas found to
increase the sensitivity of the receptors to agonist more than
10-fold (53). Disulfide bond trapping experiments on the
GABAA receptor (54) and EPR experiments on GLIC (55) also
support heightened dynamics at the EC end of TM2 during
channel gating. Our previous work on the glycine receptor
suggested that increasing or decreasing the conformational
dynamics at the EC end of TM2 could respectively increase or
decrease the susceptibility of the channel to allosteric modula-
tion (51). Thus, it is conceivable that changing dynamics of the
EC end of the TM domain, either via drug binding or via point
mutations, is a commonmechanism to modulate the functions
of pLGICs.
Our study not only highlights the importance of the anes-
thetic binding site but also emphasizes the role of channel
dynamics in anesthetic action. Although 2 and 7 have high
sequence homology, the dynamics and subtle structural differ-
ences are sufficient to affect anesthetic binding as well as func-
tional consequences. Anesthetic binding is necessary but not
sufficient to produce a functional consequence. Only the bind-
ing that modulates dynamics of pore-lining residues, such as
that at the EC end of the 2 TM domain, can impact function.
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